Full Text View
Tabular View
No Study Results Posted
Related Studies
An Open-Label Study to Evaluate the Safety and Efficacy of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
This study has been terminated.
Study NCT00677872   Information provided by Epix Pharmaceuticals, Inc.

First Received on May 13, 2008.   Last Updated on July 28, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
COPD
Pulmonary Hypertension
Additional conditions recognized in this trial
Hypertension
Hypertension, Pulmonary
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
More general conditions related to this trial
Cardiovascular Diseases
Respiratory Tract Diseases
Vascular Diseases
Interventions listed in this trial
PRX-08066
Sponsors listed in this trial
Epix Pharmaceuticals, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services